e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 10

Effects of Acyclovir and IVIG on Behavioral Outcomes after HSV1 CNS Infection

Chandran Ramakrishna; Mari S. Golub; Abby J. Chiang; Teresa Hong; Markus Kalkum; Edouard M. Cantin · 2017 · Behavioural Neurology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Herpes simplex virus 1 (HSV) encephalitis (HSE) has serious neurological complications, involving behavioral and cognitive impairments that cause significant morbidity and a reduced quality of life. We showed that HSE results from dysregulated central nervous system (CNS) inflammatory responses. We hypothesized that CNS inflammation is casually involved in behavioral abnormalities after HSE and that treatment with ACV and pooled human immunoglobulin (IVIG), an immunomodulatory drug, would improve outcomes compared to mice treated with phosphate buffered saline (PBS) or ACV alone. Anxiety level

Abstract by Chandran Ramakrishna; Mari S. Golub; Abby J. Chiang; Teresa Hong; Markus Kalkum; Edouard M. Cantin, Behavioural Neurology (2017) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1155/2017/5238402